About
Liposomal Therapeutics
Areas of Focus
Categories
Drug Delivery & FormulationMiddle East
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
120
By Phase
PHASE1/PHASE2: 1NA: 1PHASE1: 1
By Status
RECRUITING: 1NOT_YET_RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06193421Lead Sponsor
High-Dose Ambroxol in GBA1-Related Parkinson
PHASE1/PHASE2Recruiting
40 participants
Started: Oct 24, 2023 · Completed: Apr 30, 2025
NCT05946954Lead Sponsor
Immediate Implant Placement Using Immediate Dentoalveolar Restoration Versus Ice Cream Cone Technique With Labial Plate Dehiscence
NANot yet recruiting
28 participants
Started: Oct 1, 2023 · Completed: Dec 30, 2025
NCT03681548Lead Sponsor
A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer.
PHASE1Completed
52 participants
Started: Aug 29, 2018 · Completed: Mar 7, 2019
Locations (1)
Headquarters
Jerusalem, Israel
Map
Loading map...